R

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Executive Director - Global Marketing, PDAC Cancer Strategy & Ops

Marketing Generalist & ManagementPosted on Nov 9
Full-time

About the Job

Requirements

  • A bachelor's degree is required; an advanced degree such as an MBA, PhD, PharmD, or equivalent is preferred.
  • At least 15 years of progressive commercial experience in biotechnology and/or pharmaceuticals, including global strategic marketing or global brand responsibilities; local or affiliate marketing experience is also required.
  • Deep oncology expertise, including understanding oncology drug development, standards of care, clinical practice, and unmet needs. Pancreatic cancer experience is valuable, or broader oncology experience with the ability to quickly build disease-area expertise.
  • Ability to interpret clinical evidence, study design, and development strategy and assess implications for patients, treatment pathways, and commercial opportunities across assets and indications.
  • Experience collaborating with Medical Affairs and Clinical Development as a trusted commercial partner, incorporating medical and scientific expertise and working within clear functional roles and responsibilities.
  • Ability to build relationships, facilitate constructive discussion, and influence cross-functional stakeholders without relying on direct authority; help teams align on evidence and translate perspectives into portfolio and brand strategies.
  • Experience supporting commercialization organizations, including launch readiness, brand planning, operational planning, and capability buildout.
  • Executive Director-level capability, including defining operating models, building scalable organizational capabilities, and driving cross-functional alignment in evolving organizations.
  • Track record developing and executing global brand strategies and translating insights into executable plans and deliverables.
  • Launch experience at the global, regional, or major-market level, with responsibility for core brand strategy, messaging, and enabling assets.
  • Experience partnering with senior commercial, medical, sales, analytics, and access leaders to enable organizational effectiveness.
  • Experience building and scaling high-performing teams and organizational capabilities.
  • Ability to thrive in ambiguous, fast-moving environments with a hands-on, builder mindset.
  • Ability to represent companies externally with strong results and relationships.

Responsibilities

  • Partner with clinical, commercial, medical, access, and other teams to evolve disease-area strategy based on current internal and competitive evidence; support prioritization of future assets for development, in-licensing, or combinations; partner with business development; and share commercial and clinical insights across functions.
  • Partner with Medical and Market Access to develop, track, and refresh the multi-year pancreatic cancer commercialization plan across assets and indications; share learnings with Lung and CRC teams and coordinate input into the cross-tumor plan.
  • Align with pancreatic cancer and other tumor commercial and medical teams on strategic elements consistent across indications, including overarching positioning, global brand campaigns, brand books, and consistent dosing and mechanism-of-action messages; improve cross-team communication and implement shared strategic elements consistently.
  • Lead global thought leader strategy and coordination, including leading the Senior Director, Global Thought Leader Strategy & Engagement for pancreatic cancers; develop a portfolio-wide engagement approach, coordinate external engagement priorities and relationships, and incorporate interaction insights into disease-area and commercial strategies.
  • Shape cross-functional operating practices in a growing organization by bringing clarity, structure, and momentum while partnering with senior leaders.
  • Support pancreatic cancer team meetings to ensure preparation, broad input, and seamless execution; plan team-building initiatives; build team culture, communications, and efficiency; and drive coordinated annual planning, including brand planning and forecast updates.
  • Lead a director or senior director coordinating pancreatic cancer commercial input into early development, and attend early asset meetings as needed based on the agenda.
  • Lead development and ongoing evolution of the pancreatic cancer portfolio narrative, articulating the disease-area opportunity, portfolio strategy, and role of each brand and indication; align brand and indication teams on co-positioning and portfolio-level messages while keeping brand strategies differentiated and grounded in clinical profiles.
  • Travel as needed, typically up to 30–45%.

Desired Qualifications

  • Experience in pancreatic cancer is valuable; broader oncology experience with the ability to quickly build disease-area expertise is also relevant.
  • An advanced degree such as an MBA, PhD, PharmD, or equivalent.

About the Company

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Redwood City, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Revolution Medicines

See more jobs